Is Teva A Falling Drug Company Or A Great Value Proposition (NYSE:TEVA) | Seeking Alpha
Teva shares hit 19-year low after opioid settlement, analyst downgrades | Fierce Pharma
Teva: Another Day, Another Downgrade - Barron's
TEVA: A Pharma Stock to Watch | Mish's Market Minute | StockCharts.com
Teva Pharmaceutical Is in Recovery - WSJ
Teva shares climb as third-quarter sales top estimates - MarketWatch
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
Teva earnings preview: Opioid suits are 'key' - MarketWatch
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
Teva to pay $225M to settle cholesterol drug price-fixing charges
TEVA Stock Price | Teva Pharmaceutical Industries Ltd. ADR Stock Quote (U.S.: NYSE) | MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Billionaire health-care investor Phillip Frost charged by SEC with pump-and-dump schemes - MarketWatch
Drug maker Teva's U.S. unit indicted on price-fixing charges - MarketWatch
Teva's Austedo, Ajovy sales offset Q4 declines in generics
Teva lifts forecast as Q3 sales top estimates
Teva stock drops on guidance, manufacturing problems - MarketWatch
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva's new plan is to raise drug prices, but it won't be easy - MarketWatch
After Mylan uproar, a generic EpiPen could hit the market in 2017 - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Teva to acquire Mexico's Rimsa for $2.3 billion - MarketWatch
Teva to lay off 14,000 workers in bid for survival — but some are skeptical - MarketWatch
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Israeli stocks slump in first day of trade since Gaza attack - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
